ABSTRACT VASP (vasodilator-stimulated phosphoprotein), an established substrate of cAMP-and cGMP-dependent protein kinases in vitro and in living cells, is associated with focal adhesions, microfilaments, and membrane regions of high dynamic activity. Here, the identification of an 83-kDa protein (p83) that specifically binds VASP in blot overlays of different cell homogenates is reported. With VASP overlays as a detection tool, p83 was purified from porcine platelets and used to generate monospecific polyclonal antibodies. VASP binding to purified p83 in solid-phase binding assays and the closely matching subcellular localization in double-label immunofluorescence analyses demonstrated that both proteins also directly interact as native proteins in vitro and possibly in living cells. The subcellular distribution, the biochemical properties, as well as microsequencing data revealed that porcine platelet p83 is related to chicken gizzard zyxin and most likely represents the mammalian equivalent of the chicken protein. The VASP-p83 interaction may contribute to the targeting ofVASP to focal adhesions, microfilaments, and dynamic membrane regions. Together with our recent identification of VASP as a natural ligand of the profilin poly-(L-proline) binding site, our present results suggest that, by linking profilin to zyxin/p83, VASP may participate in spatially confined profilin-regulated F-actin formation.
protein (p83) that specifically binds VASP in blot overlays of different cell homogenates is reported. With VASP overlays as a detection tool, p83 was purified from porcine platelets and used to generate monospecific polyclonal antibodies. VASP binding to purified p83 in solid-phase binding assays and the closely matching subcellular localization in double-label immunofluorescence analyses demonstrated that both proteins also directly interact as native proteins in vitro and possibly in living cells. The subcellular distribution, the biochemical properties, as well as microsequencing data revealed that porcine platelet p83 is related to chicken gizzard zyxin and most likely represents the mammalian equivalent of the chicken protein. The VASP-p83 interaction may contribute to the targeting ofVASP to focal adhesions, microfilaments, and dynamic membrane regions. Together with our recent identification of VASP as a natural ligand of the profilin poly-(L-proline) binding site, our present results suggest that, by linking profilin to zyxin/p83, VASP may participate in spatially confined profilin-regulated F-actin formation.
Focal adhesions are transmembrane junctions between terminal portions of microfilaments and the underlying extracellular matrix with the heterodimeric integrins as the prevailing transmembrane adhesive receptors (1) (2) (3) . Understanding of the molecular basis of integrin-dependent cell adhesion and associated signaling events (4, 5) requires elucidation of the focal adhesion architecture. Based mostly on in vitro assays, multiple low-to-moderate affinity interactions have been shown that allow the construction of several interdigitating routes that appear to link actin filaments to the transmembrane integrins and provide docking points for different regulatory proteins (for a review, see refs. [1] [2] [3] . For instance, vinculin interacts with a-actinin and talin, which both bind to the cytoplasmic domains of integrin ,B subunits, and all three of them have actin-binding activity. Vinculin and a-actinin in addition have been recognized as paxillin-and zyxin-binding proteins, respectively. Although considerable insight into the molecular composition and structural organization of focal adhesions has been gained (1-3), current concepts concerning the functional relationships between individual constituents are still quite fragmentary.
Originating from the analyses of cyclic nucleotide-dependent platelet inhibition, we characterized and purified the vasodilator-stimulated phosphoprotein (VASP) as an in vitro and in vivo substrate of cAMP-and cGMP-dependent protein kinases (6) (7) (8) . Cyclic nucleotide-dependent VASP phosphorylation lies at a point of convergence of two signaling pathways that inhibit platelet activation and associated events like adhesion, shape change, and aggregation (9). Subsequently, VASP was shown to localize to focal adhesions, stress fibers, highly dynamic membrane regions, and cell-cell contacts of certain epithelial cells (10, 11) . Molecular cloning established VASP as a novel protein with a unique proline-rich central domain (11) . Very recently, we identified VASP as a natural ligand for the poly(L-proline)-binding site of profilin (12) . Both VASP and the G-actin and phosphatidylinositol phosphates-binding protein profilin are important members of signal-transduction pathways (9, 13, 14) and may act in concert to relay signal transduction to the actin cytoskeleton. Therefore, it is of considerable interest to identify additional VASP-binding proteins in order to define the structural and functional integration of VASP at its subcellular locations. Here we report the identification and purification of a 83-kDa VASPbinding protein and its characterization as a mammalian protein related to chicken zyxin (15) (16) (17) .
MATERIALS AND METHODS
Purification of VASP. VASP was purified from human platelets essentially as described (6) with the modifications indicated (10) .
Porcine platelet VASP was purified as a byproduct of p83. Pooled hydroxylapatite fractions (40-100 mM phosphate) obtained during the purification of p83 from the particulate platelet fraction (see below) were subjected to sequential orange A and Mono-S HR chromatography (6) followed by a final hydroxylapatite step.
[32P]VASP Overlay. For [32P]VASP overlays, proteins were separated by SDS/PAGE and blotted onto nitrocellulose. Nitrocellulose sheets were blocked as described (10) and were incubated for at least 30 min at room temperature with
[32P]VASP at 0.1 ,ug/ml in blocking medium (10) supplemented with 0.5 mM dithiothreitol. Nitrocellulose sheets were washed three times for 5 min with phosphate-buffered saline (PBS) containing 0.3% Triton X-100, 0.05% Tween 20, and 0.5 mM dithiothreitol. Dried sheets were exposed to an autoradiographic film.
For radiolabeling of VASP, porcine platelet VASP was phosphorylated by cGMP-dependent protein kinase (6) Purification of p83. The soluble fraction (45,900 x g supernatant) of a hypotonic platelet lysate, obtained from 8 x 1012 porcine platelets essentially as described (6) , was subjected to one additional freeze/thaw cycle, adjusted to pH 7.0, cleared by centrifugation, and applied to an S-Sepharose FF (Pharmacia) column (4 x 33 cm). This and all subsequent steps were performed at 4°C. Alternatively, a 250 mM NaCl extract of the particulate platelet fraction dialyzed against buffer A (10 mM NaPi, pH 7.0/4 mM EDTA/50 mM 2-mercaptoethanol) was used as starting material for S-Sepharose FF-chromatography.
Proteins were eluted from the S-Sepharose FF column with a 1000-ml gradient from 0 to 500 mM NaCl prepared in buffer A. Fractions that were positive for p83 in the [32P]VASP overlay procedure were pooled, and p83 was precipitated by the addition of solid ammonium sulfate (final concentration, 30% saturation). The precipitate was dissolved in about 6 ml of buffer A containing 75 mM NaCl, dialyzed against the same buffer, and loaded (0.5 ml/min) onto a column of 5-6 ml of hydroxylapatite (Bio-Gel HT, Bio-Rad). The column was eluted (1 ml/min) with a 35-ml linear gradient from 10 mM KH2PO4 adjusted with NaOH to pH 7.5 containing 50 mM 2-mercaptoethanol and 75 mM NaCl to 100 mM KH2PO4/ NaOH (pH 7.5) containing only 50 mM 2-mercaptoethanol. P83-containing fractions were pooled, dialyzed against 10 mM KH2PO4/NaOH, pH 7.5/150 mM NaCl and applied (0.25 ml/min) to a 1-ml HiTrap chelat column (Pharmacia), precharged with 500 ,1 of 100 mM ZnCl2. The column was washed with buffer B (25 mM sodium borate, pH 7.5/1 M NaCl). Contaminating proteins together with some p83 were eluted (0.5 ml/min) by 15 ml of 0.25 mM ZnCl2 in buffer B. Subsequent elution with 1 mM ZnCl2 in buffer B yielded apparently homogeneous p83 as judged from Coomassie bluestained gels. After removal of the ZnCl2, p83 was dialyzed against 25 mM Tris-HCl, pH 8.0/0.1 mM EGTA/150 mM NaCl/0.015% Nonidet P-40 (Boehringer Mannheim)/20% (vol/vol) glycerol/0.5 mM dithiothreitol for storage at -80°C. Alternatively, protamine agarose chromatography was used as the final purification step. The sample eluted from the hydroxylapatite column was applied (0.25 ml/min) to 2.5 ml of protamine agarose (Sigma) in 10 mM KH2PO4/NaOH, pH 7.5/150 mM NaCl/4 mM EDTA/50 mM 2-mercaptoethanol/ 20% glycerol. The column was washed with the same buffer containing 2 M NaCl and eluted (0.5 ml/min) with 300 mM arginine hydrochloride (pH 9.0)/2 M NaCl/4 mM EDTA/50 mM 2-mercaptoethanol, yielding essentially pure p83. Concentrations of purified p83 were estimated from Coomassie blue-stained gels using bovine serum albumin as a standard.
Immunological Methods. A New Zealand White female rabbit was immunized with electrophoretically purified and electroeluted p83 starting from partially purified preparations. The p83 rabbit antiserum AS83-1 and a polyclonal mouse anti-VASP serum were affinity-purified essentially as described (18) by using the respective purified proteins blotted onto nitrocellulose. Immunoblotting (Western blotting) and immunofluorescence analysis were done essentially as described (10) .
Solid-Phase Binding Assay. Solid-phase binding assays were done essentially as described (12) (Fig. 1) . Occasionally, additional smaller bands of various sizes were observed, which most likely represented degradation products (e.g., see Fig. 3 2'). Competition with a 10-to 50-fold excess to unlabeled VASP quenched [32P]VASP binding to p83, demonstrating that this interaction is specific and saturable (Fig. 1) .
Purification of p83 from Porcine Platelets. P83 was purified from porcine platelets as outlined in Fig. 2A by using [32P]VASP overlays as a detection tool. Detection of the VASP-binding protein p83 was strongly dependent op the presence of a specific fibrinogen receptor (integrin a1nb33) antagonist or on high concentrations of a Ca2+ chelator during platelet preparation or platelet lysis, respectively (not shown), suggesting that p83 is susceptible to platelet aggregationdependent proteolysis by calpain (21, 22) . In a first chromatographic step VASP-binding activity was recovered at neutral pH in the 70-220 mM NaCl eluate of a cation exchanger (S-Sepharose FF) and was nearly quantitatively precipitated by the addition of ammonium sulfate (30% saturation). In a subsequent hydroxylapatite step, about half of the p83 loaded onto the column was recovered with an equivalent of 25-40 mM phosphate-i.e., before the bulk of other proteins was eluted. Therefore, hydroxylapatite chromatography is an efficient purification step. Fractions eluted with 40-60 mM phosphate, though containing most of the remaining p83, were discarded because coeluting contaminants were difficult to remove. Finally, proteins from pooled fractions were separated on a chelating column that had been precharged with ZnCl2.
Elution with 250 ALM ZnCl2 yielded both p83 and several lower molecular weight proteins (Fig. 2B, lane 1) , whereas subsequent elution with 1 mM ZnCl2 resulted in apparently homogeneous p83 (Fig. 2B, lane 2) . Alternatively, chromatography on protamine agarose and arginine (pH 9.0) elution was used as a final purification step with similar efficiency. From a total of 8 x 1012 platelets, obtained from 60 liters of porcine blood, -10-20 ,ug of p83 could be purified. VASP and p83 Interact as Native Proteins. Blot overlays showed that VASP binds to denatured p83. Therefore, it was of interest to examine whether VASP and p83 also interact as native proteins. This question was addressed by using solidphase binding assays in which purified p83 was coated to the surface of microtiter wells and VASP was applied as a soluble ligand. VASP strongly bound to surface-coated p83, demonstrating that the native proteins interact directly (data not shown).
VASP and p83 Show a Closely Matching Subcellular Distribution. A rabbit antiserum AS83-1 raised against porcine platelet p83 was characterized in Western blots of porcine and human platelets, chicken blood cells, and human skin fibroblasts. In all but the chicken cells, p83 was specifically stained. In the human platelet preparation, minor putative degradation products were also labeled by AS83-1 antiserum (Fig. 3, lane  2" ).
[32P]VASP overlays of proteins from chicken blood cells revealed VASP binding to a protein of slightly smaller size (Fig. 3, lane 3' ), which did not react with the antiserum (Fig.  3, lane 3") . Some species selectivity of AS83-1 antiserum was also evident when labeling of porcine and human p83 were compared ( Fig. 3 ; compare lanes 1' and 2' to lanes 1" and 2"; note that the protein applied in lane 1" is 20% of that in other lanes).
If VASP and p83 interact directly in living cells, they are expected to display an overlapping subcellular distribution. This was investigated by double-label immunofluorescence using the monospecific rabbit antiserum (AS83-1) raised against porcine platelet p83 and a polyclonal mouse anti-VASP serum S2. Fig. 4 presents a comparison of VASP and p83 localization in human dermal fibroblasts. The subcellular localization of both proteins was indistinguishable. In particular, focal adhesions, microfilaments of stress fibers (Fig. 4 a,  a' , b, and b'), and arcs (not shown), and the periphery of protruding lamellae (Fig. 4 c and c') were labeled both by affinity-purified antibodies and the original antisera against VASP (Fig. 4 a '-c'; ref. 10) and p83 (Fig. 4 a-c gm.] decoration with p83 showed the same periodicity and spacing and coincided with that of VASP (data not shown).
P83 Is a Zyxin-Related Protein. Partially purified p83 (hydroxylapatite eluate) was separated by SDS/PAGE, excised from the gel, and subjected to proteolytic digestion. Microsequencing of the resulting peptides yielded two peptide sequences of 27 (peptide A) and 24 (peptide B) amino acids in length. Both exhibited significant (average z values > 8) but limited homology to chicken zyxin sequences (Fig. 5) within the proline-rich and third LIM domain, respectively (23) .
These data suggested that p83 is a zyxin-related protein, possibly the mammalian homologue of the chicken gizzard protein. Zyxin, a low-abundance focal adhesion and stress fiber-associated a-actinin-binding protein (15, 16, 24) , has previously been purified from chicken gizzard (16) . In human platelets, a possible zyxin homologue has been observed, which has a somewhat higher apparent molecular mass (84 kDa) than the 82-kDa chicken protein (25) . This is in agreement with the apparent molecular mass difference observed between mammalian ( Fig. 3, lanes 1', 2' , and 4') and chicken (Fig. 3, lane 3' ) VASP-binding proteins. To investigate whether the chicken protein that was recognized by VASP in blot overlays is identical with zyxin, chicken blood cell proteins were separated by 2-D gel electrophoresis followed by a [32P]VASP overlay. As shown in Fig. 6 derived from dilution experiments with purified p83 demonstrated that about 30 ng are readily detectable in [32P]VASP overlays (not shown). P83 purified here from porcine platelets was characterized as a zyxin-related protein, based on biochemical and microsequencing data. In addition, the subcellular distribution of p83, as revealed by indirect immunofluorescence, closely matches that of chicken zyxin (15, 16, 24) -i.e., both proteins are predominarktly associated with focal adhesions and stress fibers in a characteristic periodic pattern. Taken together, these data suggest that p83 is most likely the mammalian equivalent of chicken zyxin. However, the alignment of peptides A and B from p83 to the chicken zyxin sequence indicates a lower degree of evolutionary conservation when compared to other focal adhesion proteins, such as vinculin and nonmuscle a-actinin from man and chicken (overall identities, 95-96%). Both the AS83-1 antiserum raised against porcine platelet p83 (our present data) and the original rabbit serum recognizing chicken zyxin (17) showed limited interspecies crossreactivity, pointing to obvious species differences between both proteins.
Two more zyxin-binding proteins have been detected previously. Zyxin binds to the N-terminal 27-kDa domain of the focal adhesion-and microfilament-associated actin-binding protein a-actinin (24) and to the 23-kDa LIM-domain protein cCRP (chicken cysteine-rich protein) (23) . Schmeichel and Beckerle (26) demonstrated that most of the CRP-binding activity resides in the first of three zyxin LIM-domains (amino &cids 349-406), whereas the a-actinin binding site is located in the zyxin N-terminal proline-rich domain (amino acids 1-348). Recent data suggested that this proline-rich domain may also be involved in the zyxin-VASP interaction: thus, VASP has been shown to bind to the Listeria monocytogenes surface protein ActA (27) . This interaction involves the 4-fold repeated ActA proline-rich motifs (Asp or Glu)-Phe-Pro-Pro-(Pro or Ile)-Pro-Thr-(Asp or Glu)-(Glu or Asp)-Glu-Leu (28), which resemble several sequences located in the zyxin Nterminal domain between residues 81 and 134 (23) . Moreover, microinjection of a corresponding ActA peptide caused a diffuse cytosolic VASP distribution and complete depletion of VASP from lamellipodia and focal adhesions (28) , where it normally colocalizes with p83 or zyxin, respectively.
VASP also interacts with the actin regulatory protein profilin (12) . Both VASP-binding proteins, listerial ActA (29, 30) and host-cell profilin (31) , are involved in the actin-based motility of the intracellular bacterial parasite L. monocytogenes. Considering the function of profilin in actin polymerization (32) and the direct interaction with VASP, VASP might link profilin to other proteins, like ActA and p83/zyxin and thus confine profilin-regulated F-actin formation to defined subcellular sites. This may be especially relevant at the leading edge of migrating cells, where VASP, p83, and profilin (33), as well as highly dynamic actin polymerization are found (2, (34) (35) (36) (37) . Similarly, VASP and p83/zyxin localization to focal adhesions and stress fibers may contribute to the actin turnover observed at these sites (37) .
In the near future, further molecular characterization of p83 and VASP should allow definition of the interaction between these proteins in more detail and investigation of their possible involvement in spatially confined actin polymerization.
